Article

Assessing the Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-analysis of COMS and NHS Cohorts

2024-09-10

Abstract excerpt

<title>Abstract</title> <p><bold>Objective:</bold> To evaluate if there is a survival benefit of primary tumor treatment in uveal melanoma by comparing patients who declined treatment (Natural History Study, NHS) with those who received treatment in the Collaborative Ocular Melanoma Study (COMS) for medium-sized choroidal melanomas. <bold>Design:</bold> Retrospective cohort study using reverse-engineered survival...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a37180a7-c63e-5d93-8ec7-da7a4f40e757
DOI: 10.21203/rs.3.rs-5058314/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Assessing the Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-analysis of COMS and NHS CohortsDOI 10.21203/rs.3.rs-5058314/v1Read

Estimating Cured Fractions of Uveal Melanoma.Semantic proximity Read

Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors.Semantic proximity Read

Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status.Semantic proximity Read

Timing of Radiotherapy in Uveal Melanoma: A SEER-Based Comparison of Preoperative, Postoperative, and Intraoperative ApproachesSemantic proximity Read

A retrospective study of anti-PD-1 combined with temozolomide adjuvant therapy for stage III resected acral melanomaSemantic proximity Read

Consensus-Derived Risk Stratification to Guide Surveillance in Primary Uveal Melanoma: The PRIME Delphi StudySemantic proximity Read

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.Semantic proximity Read

Adjuvant pembrolizumab versus high-dose interferon α-2b for Chinese patients with resected stage III melanoma: a retrospective cohort study.Semantic proximity Read

Prognostic value of the number of biopsied sentinel lymph nodes for Chinese patients with melanoma: A single-center retrospective studySemantic proximity Read

The role of BRAF mutations in primary melanoma growth rate and survival.Semantic proximity Read

Five-year outcomes from a phase 3 METRIC study in patients with BRAF V600 E/K–mutant advanced or metastatic melanomaSemantic proximity Read

Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma.Semantic proximity Read